| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0735-1097(97)00324-0 |
| P698 | PubMed publication ID | 9350917 |
| P50 | author | Christian Weber | Q37838769 |
| P2093 | author name string | K S Weber | |
| P C Weber | |||
| C Weber | |||
| W Erl | |||
| P2860 | cites work | Integrin activation by R-ras. | Q45995226 |
| Functionally abnormal monocytes in hypercholesterolemia | Q57398964 | ||
| Enhancement of Monocyte Adhesion to Endothelial Cells by Oxidatively Modified Low-Density Lipoprotein Is Mediated by Activation of Cd11B | Q63915293 | ||
| Role of Rho in chemoattractant-activated leukocyte adhesion through integrins | Q70960218 | ||
| Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers | Q71018428 | ||
| Monocytes from patients with combined hypercholesterolemia-hypertriglyceridemia and isolated hypercholesterolemia show an increased adhesion to endothelial cells in vitro: II. Influence of intrinsic and extrinsic factors on monocyte binding | Q72618768 | ||
| Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages | Q72940400 | ||
| Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm | Q29547181 | ||
| Regulation of the mevalonate pathway | Q29547763 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 | ||
| Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases | Q34762451 | ||
| Increased surface expression of CD11b/CD18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium | Q35585847 | ||
| A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen | Q36232276 | ||
| Prenyl proteins in eukaryotic cells: a new type of membrane anchor | Q37923158 | ||
| Lovastatin increases arachidonic acid levels and stimulates thromboxane synthesis in human liver and monocytic cell lines | Q40333644 | ||
| Lovastatin induces differentiation of Mono Mac 6 cells | Q41264951 | ||
| Adhesion properties of Mono Mac 6, a monocytic cell line with characteristics of mature human monocytes | Q41377710 | ||
| Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals | Q41441087 | ||
| Lovastatin inhibits receptor-stimulated Ca(2+)-influx in retinoic acid differentiated U937 and HL-60 cells | Q41445200 | ||
| Rapid G protein-regulated activation event involved in lymphocyte binding to high endothelial venules | Q42118588 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1212-1217 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia | |
| P478 | volume | 30 |
| Q34762159 | Acetate supplementation attenuates lipopolysaccharide-induced neuroinflammation |
| Q27015967 | Adhesion molecules in CNS disorders: biomarker and therapeutic targets |
| Q58064445 | Adhesion molecules in inflammatory diseases |
| Q38507097 | Aneurysmal vasculopathy in human-acquired immunodeficiency virus-infected adults: Imaging case series and review of the literature |
| Q36490986 | Angiotensin II AT1 receptor blockade normalizes CD11b+ monocyte production in bone marrow of hypercholesterolemic monkeys |
| Q44784592 | Anti-inflammatory effects of pravastatin on Helicobacter pylori-induced gastritis in mice |
| Q28176000 | Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia |
| Q36337932 | Anti-inflammatory effects of statins: clinical evidence and basic mechanisms |
| Q34644504 | Antiinflammatory and immunomodulatory properties of statins |
| Q24792912 | Are statins anti-inflammatory? |
| Q44225696 | Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community |
| Q33828323 | Atheroprotective effects of statins in patients with unstable angina by regulating the blood-borne microRNA network |
| Q34990177 | Atherosclerosis and cancer: common pathways on the vascular endothelium. |
| Q35556348 | Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins |
| Q36392153 | Atorvastatin Reduces the Survival of Candida albicans-Infected BALB/c Mice |
| Q43942237 | Atorvastatin activates PPAR-gamma and attenuates the inflammatory response in human monocytes |
| Q43218018 | Atorvastatin attenuates murine anti-glomerular basement membrane glomerulonephritis |
| Q44249484 | Atorvastatin reduces expression of leukocyte adhesion molecules in patients with hypercholesterolemia. |
| Q44064914 | Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes |
| Q37507632 | Can we use statins to prevent stroke in Fabry disease? |
| Q34756141 | Cerivastatin does not prevent oxidative injury of human aortic endothelial cells. |
| Q33777699 | Cholesterol lowering and endothelial function |
| Q43720863 | Do statins afford neuroprotection in patients with cerebral ischaemia and stroke? |
| Q36203097 | Do statins prevent heart failure in patients after myocardial infarction? |
| Q50095811 | Dose-dependent effects of statins for patients with aneurysmal subarachnoid hemorrhage: meta-regression analysis. |
| Q26851763 | Effect of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor on disease activity in patients with rheumatoid arthritis: a meta-analysis |
| Q43571946 | Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study |
| Q43687661 | Effect of simvastatin on monocyte adhesion molecule expression in patients with hypercholesterolemia |
| Q73980526 | Effectiveness of antihyperlipidemic drug management in clinical practice |
| Q73328285 | Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study |
| Q44663084 | Effects of statins on adhesion molecule expression in endothelial cells |
| Q35077217 | Effects of statins on the vasculature: Implications for aggressive lipid management in the cardiovascular metabolic syndrome |
| Q59341933 | El monocito/macrófago como diana terapéutica en la aterosclerosis |
| Q35093076 | Endothelium and the lipid metabolism: the current understanding. |
| Q52689529 | Exploring the In Vivo Anti-Inflammatory Actions of Simvastatin-Loaded Porous Microspheres on Inflamed Tenocytes in a Collagenase-Induced Animal Model of Achilles Tendinitis. |
| Q36553647 | Fluvastatin Suppresses Mast Cell and Basophil IgE Responses: Genotype-Dependent Effects. |
| Q46574967 | HMG-CoA reductase inhibitors deplete circulating classical and non-classical monocytes following human heart transplantation |
| Q36178921 | How aggressive should lipid lowering be among patients with acute coronary syndromes? |
| Q73409194 | Hydroxymethylglutaryl-coenzyme A reductase inhibition stimulates caspase-1 activity and Th1-cytokine release in peripheral blood mononuclear cells |
| Q39592615 | Hypercholesterolemia induces leukocyte entrapment in the retinal microcirculation of rats |
| Q35008533 | Hypolipemic agents for stroke prevention. |
| Q36888917 | In vivo effect of statins on the expression of the HIV co-receptors CCR5 and CXCR4 |
| Q44011679 | Increased transforming growth factor-beta(1) circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibition with pravastatin |
| Q34027327 | Inflammation and lipid-lowering treatment |
| Q37871076 | Inflammatory predictors of mortality in the Scandinavian Simvastatin Survival Study |
| Q39778606 | Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4. |
| Q52218975 | Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia. |
| Q43909326 | Interaction between blood pressure, lipoproteins, angiotensin, and vascular disease |
| Q42809300 | Isoprenylation of RhoB is necessary for its degradation. A novel determinant in the complex regulation of RhoB expression by the mevalonate pathway |
| Q40650139 | LDL activates signaling pathways leading to an increase in cytosolic free calcium and stimulation of CD11b expression in monocytes |
| Q36070412 | Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis |
| Q42819316 | Long‐Term Statin Therapy Affects the Severity of Chronic Gastritis |
| Q42177739 | Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis |
| Q34557178 | Ly6C(low) and not Ly6C(high) macrophages accumulate first in the heart in a model of murine pressure-overload |
| Q92596466 | Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer |
| Q46082567 | Metformin and atorvastatin reduce adhesion formation in a rat uterine horn model. |
| Q35026501 | Microcirculation as a target for the anti-inflammatory properties of statins. |
| Q34081563 | Microvascular dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon |
| Q33937127 | Modulation of vascular cell activation, function, and apoptosis: role of antioxidants and nuclear factor-kappa B. |
| Q34027314 | Non-lipid-lowering effects of statins on atherosclerosis |
| Q73110406 | Peripheral blood mononuclear cell production of interleukin-8 and IL-8-dependent neutrophil function in hypercholesterolemic patients |
| Q34773911 | Pharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatin |
| Q33944801 | Plaque stabilization: the role of lipid lowering |
| Q36025981 | Pleiotropic effects of statins: moving beyond cholesterol control |
| Q37403235 | Pleiotropic vasoprotective effects of statins: the chicken or the egg? |
| Q35148377 | Post-stroke inflammatory response: effects of stroke evolution and outcome |
| Q35561907 | Potential Role of Statins in Inflammation and Atherosclerosis |
| Q73337591 | Pravastatin down-regulates inflammatory mediators in human monocytes in vitro |
| Q35077221 | Prevention of stroke and dementia with statins: Effects beyond lipid lowering |
| Q90304215 | Psammomys obesus: a Natural Diet-Controlled Model for Diabetes and Cardiovascular Diseases |
| Q40155137 | Pulmonary Infections in the Elderly Lead to Impaired Neutrophil Targeting, Improved by Simvastatin |
| Q43955489 | Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease |
| Q44082424 | Reduction of bFGF-induced smooth muscle cell proliferation and endothelin receptor mRNA expression by mevastatin and atorvastatin. |
| Q43801142 | Secondary prevention with fluvastatin decreases levels of adhesion molecules, neopterin and C-reactive protein |
| Q34084221 | Should intensive cholesterol lowering play a role in the management of acute coronary syndromes? |
| Q35581141 | Simvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypass |
| Q58421218 | Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia |
| Q41429627 | Simvastatin protects against cholestasis-induced liver injury |
| Q34305806 | Simvastatin reduces endotoxin-induced acute lung injury by decreasing neutrophil recruitment and radical formation |
| Q42958893 | Statin Modulation of Human T-Cell Proliferation, IL-1β and IL-17 Production, and IFN-γ T Cell Expression: Synergy with Conventional Immunosuppressive Agents. |
| Q28236647 | Statin therapy and autoimmune disease: from protein prenylation to immunomodulation |
| Q36684187 | Statins and biomarkers of inflammation |
| Q34482145 | Statins and inflammatory markers |
| Q36797719 | Statins and sepsis: multiple modifications at multiple levels. |
| Q81884102 | Statins and stroke prevention |
| Q34942903 | Statins as anti-inflammatory agents |
| Q34786108 | Statins as immunomodulators |
| Q45078529 | Statins for treatment of CNS diseases. Status report from research and clinical practice |
| Q35791924 | Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities |
| Q36085649 | Statins--a cure-all for the brain? |
| Q36963213 | Statins--treatment option for central nervous system autoimmune disease? |
| Q33876942 | Statins: effective antiatherosclerotic therapy |
| Q34687736 | Statins: mechanism of action and effects. |
| Q36428724 | Statins: panacea for sepsis? |
| Q40804462 | Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors |
| Q41585009 | Streptococcal m1 protein triggers farnesyltransferase-dependent formation of CXC chemokines in alveolar macrophages and neutrophil infiltration of the lungs |
| Q26852646 | The Role of Different Monocyte Subsets in the Pathogenesis of Atherosclerosis and Acute Coronary Syndromes |
| Q39348762 | The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration. |
| Q35059481 | The effect of rosuvastatin on thromboinflammation in the setting of acute coronary syndrome |
| Q33818141 | The evolving role of statins in the management of atherosclerosis |
| Q73131115 | The influence of treatment of hypercholesterolemic patients with simvastatin on plasma chemotactic activity and adherence of neutrophils |
| Q35153749 | The lipid and non-lipid effects of statins |
| Q35595431 | The many roles of statins in ischemic stroke |
| Q37560782 | The multifaceted profile of activated microglia. |
| Q36536154 | The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation |
| Q42475429 | Time-dependent changes in the expression of lymphocyte and monocyte cell adhesion molecules after meals of different composition |
| Q43833263 | Tocotrienol is the most effective vitamin E for reducing endothelial expression of adhesion molecules and adhesion to monocytes |
| Q34107489 | Treating ambulatory ischemia in coronary disease by manipulating the cell biology of atherosclerosis |
| Q34300585 | Use of statins in CNS disorders |
| Q36025968 | Utility of statin therapy using high-sensitivity C-reactive protein as an indicator of coronary heart disease risk |
Search more.